EMD-71589

Single-particle
11.62 Å
EMD-71589
3D View Gallery
Deposition: 03/07/2025
Map released: 24/12/2025
Last modified: 08/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-71589
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

Negative stain EM map of EBV glycoprotein gH/gL in complex with glycoprotein gp42 and HLA-DR1 Beta chain

EMD-71589

Single-particle
11.62 Å
EMD-71589
3D View Gallery
Deposition: 03/07/2025
Map released: 24/12/2025
Last modified: 08/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: human gammaherpesvirus 4, Homo sapiens
Sample: Co-expressed EBV glycoprotein gHgL Complex 1:1 with gp42, then complex 1:1 with HLA-DR1 BETA CHAIN

Deposition Authors: Lang K , Duy M, Pancera M
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.
Chhan CB, Lang K , Davis AR , Wan YH , Aldridge NT , Kher G , Scharffenberger SC , Hardy SR , Iureniev R , Giltiay NV , Edwards KR , Radtke S , Kiem HP , Pancera M , McGuire AT
(2026) Cell Rep Med , 7 , 102618 - 102618
PUBMED: 41707657
DOI: doi:10.1016/j.xcrm.2026.102618
ISSN: 2666-3791